NDC properties for "lenalidomide 2.5 MG Oral Capsule" (RxCUI 1242231)
About this data
The tables show NDC propoerties for lenalidomide 2.5 MG Oral Capsule with the RxCUI 1242231
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lenalidomide 2.5 MG Oral Capsule (RxCUI 1242231)
ANDA | ANDA201452 |
---|---|
ANDA | ANDA209348 |
ANDA | ANDA210154 |
ANDA | ANDA210480 |
ANDA | ANDA211022 |
ANDA | ANDA211846 |
ANDA | ANDA212414 |
ANDA | ANDA213885 |
ANDA | ANDA213912 |
ANDA | ANDA214618 |
MMSL_CODE | BD27635 |
MMSL_CODE | CD27635 |
RxCUI | 1242231 |
SNOMEDCT | 840661007 |
SPL_SET_ID | 51bfdd53-8fd9-4f86-bebe-75de29e6379d |
SPL_SET_ID | 76f6c1e7-985b-43d9-892c-849df50ae80e |
SPL_SET_ID | 84d9dec7-9250-4dbd-9a0d-23e75f111892 |
SPL_SET_ID | 85f5db5d-8f76-46f6-b975-6acda8c4b2c8 |
SPL_SET_ID | 96df285d-dd13-4083-b2c6-e5c799e7587b |
SPL_SET_ID | 9943e098-20b0-dbb3-af12-7816eedd3f70 |
SPL_SET_ID | 9d401422-072b-4b69-aeef-da1f9534c3ec |
SPL_SET_ID | adee5af1-c9ab-c0c7-e400-dea7d2a0d4be |
SPL_SET_ID | c98fb504-76d0-4c25-9c0b-412885828a7a |
SPL_SET_ID | ca8cc2cc-c856-e676-4f60-1e46d7b53d73 |
SPL_SET_ID | f27092f3-3977-4f4a-b214-45309e136e46 |
SPL_SET_ID | fd23328f-b019-4c14-80d9-4ebd997f26b2 |
VUID | 4031575 |
Prescribable Synonym | lenalidomide 2.5 MG Oral Capsule |
RXNAV_STR | lenalidomide 2.5 MG Oral Capsule |
RxNorm Name | lenalidomide 2.5 MG Oral Capsule |
Related queries | Interactions (for RxCUI 1242231) |
NDC Properties
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |
NDC Item 00378193501
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-01 |
NDC Item | 00378193501 |
Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-01) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00378193528
NDC 9 | 0378-1935 |
---|---|
NDC 10 | 0378-1935-28 |
NDC Item | 00378193528 |
Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-1935-28) |
ANDA | ANDA213912 |
COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
Color | C48329;C48325 __ |
FDA SPL set id | 745620 |
Imprint code | MYLAN;LL;2;5 |
Labeler | Mylan Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0378-1935 |
NDC Item 00480124128
NDC 9 | 0480-1241 |
---|---|
NDC 10 | 0480-1241-28 |
NDC Item | 00480124128 |
Packaging | 28 CAPSULE in 1 BOTTLE (0480-1241-28) |
ANDA | ANDA201452 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 782674 |
Imprint code | NAT;2;5mg |
Labeler | Teva Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-08 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 0480-1241 |
NDC Item 31722025701
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-01 |
NDC Item | 31722025701 |
Packaging | 100 CAPSULE in 1 BOTTLE (31722-257-01) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 31722025728
NDC 9 | 31722-257 |
---|---|
NDC 10 | 31722-257-28 |
NDC Item | 31722025728 |
Packaging | 28 CAPSULE in 1 BOTTLE (31722-257-28) |
ANDA | ANDA212414 |
COLORTEXT | pink,white |
Color | C48328;C48325 __ |
FDA SPL set id | 802288 |
Imprint code | H;L1 |
Labeler | Camber Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-05-11 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 15 mm |
Related queries | Properties for NDC 9 31722-257 |
NDC Item 43598051601
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-01 |
NDC Item | 43598051601 |
Packaging | 100 CAPSULE in 1 BOTTLE (43598-516-01) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 43598051663
NDC 9 | 43598-516 |
---|---|
NDC 10 | 43598-516-63 |
NDC Item | 43598051663 |
Packaging | 28 CAPSULE in 1 BOTTLE (43598-516-63) |
ANDA | ANDA209348 |
COLORTEXT | GREEN(pale green opaque colored cap),GREEN(pale green opaque colored body) |
Color | C48329;C48329 __ |
FDA SPL set id | 727151 |
Imprint code | RDY;2;5;mg |
Labeler | Dr. Reddy's Laboratories Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-09-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 43598-516 |
NDC Item 47781048301
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-01 |
NDC Item | 47781048301 |
Packaging | 100 CAPSULE in 1 BOTTLE (47781-483-01) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 47781048328
NDC 9 | 47781-483 |
---|---|
NDC 10 | 47781-483-28 |
NDC Item | 47781048328 |
Packaging | 28 CAPSULE in 1 BOTTLE (47781-483-28) |
ANDA | ANDA210480 |
COLORTEXT | BLUE(DARK BLUE),ORANGE(LIGHT ORANGE) |
Color | C48333;C48331 __ |
FDA SPL set id | 789803 |
Imprint code | LP;637 |
Labeler | Alvogen, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 47781-483 |
NDC Item 59651034201
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-01 |
NDC Item | 59651034201 |
Packaging | 100 CAPSULE in 1 BOTTLE (59651-342-01) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034207
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-07 |
NDC Item | 59651034207 |
Packaging | 1 BLISTER PACK in 1 CARTON (59651-342-07) / 7 CAPSULE in 1 BLISTER PACK |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 59651034228
NDC 9 | 59651-342 |
---|---|
NDC 10 | 59651-342-28 |
NDC Item | 59651034228 |
Packaging | 28 CAPSULE in 1 BOTTLE (59651-342-28) |
ANDA | ANDA213885 |
COLORTEXT | GREEN(Green Opaque Cap, Green Opaque Body) |
Color | C48329 __ |
FDA SPL set id | 717399 |
Imprint code | L2;5 |
Labeler | Aurobindo Pharma Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-06 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 59651-342 |
NDC Item 60505453202
NDC 9 | 60505-4532 |
---|---|
NDC 10 | 60505-4532-2 |
NDC Item | 60505453202 |
Packaging | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
ANDA | ANDA211022 |
COLORTEXT | WHITE(Opaque),BLUE(Blue green opaque) |
Color | C48325;C48333 __ |
FDA SPL set id | 794910 |
Imprint code | APO;L;2;5 |
Labeler | Apotex Corp. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 60505-4532 |
NDC Item 63304004101
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-01 |
NDC Item | 63304004101 |
Packaging | 100 CAPSULE in 1 BOTTLE (63304-041-01) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 63304004127
NDC 9 | 63304-041 |
---|---|
NDC 10 | 63304-041-27 |
NDC Item | 63304004127 |
Packaging | 28 CAPSULE in 1 BOTTLE (63304-041-27) |
ANDA | ANDA211846 |
COLORTEXT | white,white |
Color | C48325;C48325 __ |
FDA SPL set id | 701728 |
Imprint code | RL;;78 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-12 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 63304-041 |
NDC Item 69097060473
NDC 9 | 69097-604 |
---|---|
NDC 10 | 69097-604-73 |
NDC Item | 69097060473 |
Packaging | 28 CAPSULE in 1 BOTTLE (69097-604-73) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(blue green cap),WHITE(white body) |
Color | C48333;C48325 __ |
FDA SPL set id | 699517 |
Imprint code | Cipla;2;5mg;604 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-09 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 69097-604 |
NDC Item 70710103001
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-1 |
NDC Item | 70710103001 |
Packaging | 100 CAPSULE in 1 BOTTLE (70710-1030-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70710103007
NDC 9 | 70710-1030 |
---|---|
NDC 10 | 70710-1030-7 |
NDC Item | 70710103007 |
Packaging | 28 CAPSULE in 1 BOTTLE (70710-1030-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(opaque white cap),BLUE(blue opaque body) |
Color | C48325;C48333 __ |
FDA SPL set id | 770365 |
Imprint code | 1030 |
Labeler | Zydus Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70710-1030 |
NDC Item 70771167601
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-1 |
NDC Item | 70771167601 |
Packaging | 100 CAPSULE in 1 BOTTLE (70771-1676-1) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 70771167607
NDC 9 | 70771-1676 |
---|---|
NDC 10 | 70771-1676-7 |
NDC Item | 70771167607 |
Packaging | 28 CAPSULE in 1 BOTTLE (70771-1676-7) |
ANDA | ANDA210154 |
COLORTEXT | WHITE(white opaque cap with blue opaque body) |
Color | C48325 __ |
FDA SPL set id | 800438 |
Imprint code | 1030 |
Labeler | Zydus Lifesciences Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | capsule |
Shape | C48336 |
Size | 11 mm |
Related queries | Properties for NDC 9 70771-1676 |
NDC Item 76282069648
NDC 9 | 76282-696 |
---|---|
NDC 10 | 76282-696-48 |
NDC Item | 76282069648 |
Packaging | 28 CAPSULE in 1 BOTTLE (76282-696-48) |
ANDA | ANDA214618 |
COLORTEXT | BLUE(capsule blue green cap and White body) |
Color | C48333 __ |
FDA SPL set id | 792335 |
Imprint code | Cipla;2;5mg;cap;604;body |
Labeler | EXELAN PHARMACEUTICALS INC. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-06-10 |
Marketing status | active |
Score | 1 |
Shape | C48336 |
Size | 14 mm |
Related queries | Properties for NDC 9 76282-696 |